| Joel Nathan, MD | |
|
4400 W Sample Rd, Suite 154, Coconut Creek, FL 33073-3470 | |
| (954) 782-9330 | |
| (954) 977-7401 |
| Full Name | Joel Nathan |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 36 Years |
| Location | 4400 W Sample Rd, Coconut Creek, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477567311 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | ME0062339 (Florida) | Primary |
| Entity Name | Township Eye Associates Of Coconut Creek., P.a. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114110426 PECOS PAC ID: 3779778824 Enrollment ID: O20101115000629 |
News Archive
The Visiting Nurse Association of Greater Philadelphia has received a grant award from the First Hospital Foundation in the amount of $40,000. The grant will be used to enhance the VNA's Wound Care Program and will enable the agency to purchase digital cameras so the home visiting clinicians can document patients wound progression and improve wound care delivery.
BioMarin Pharmaceutical Inc. announced today that it has received orphan drug designation from the U.S. Food and Drug Administration (FDA) for BMN-701, a novel fusion of insulin-like growth factor 2 and alpha glucosidase (IGF2-GAA) in development for the treatment of Pompe disease. An investigational new drug application (IND) for BMN-701 has been submitted, investigational material has been manufactured and a Phase I/II study is expected to start in the first quarter of 2011.
K2M, Inc., today announced at the International Society for the Advancement of Spine Surgery (SAS) Conference that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the EVEREST™ Degenerative Spinal System, a versatile top-loading polyaxial pedicle screw system featuring the ability to accommodate multiple levels of fixation rigidity to help surgeons individualize patient care.
A team of researchers in Poland who treated three of six paraplegics with spinal cord injury using transplanted olfactory ensheathing cells found that the three treated patients showed neurological improvement and no adverse effects while the three control patients who did not receive transplants saw no improvement.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Joel Nathan, MD 4400 W Sample Rd, Suite 154, Coconut Creek, FL 33073-3470 Ph: (954) 782-9330 | Joel Nathan, MD 4400 W Sample Rd, Suite 154, Coconut Creek, FL 33073-3470 Ph: (954) 782-9330 |
News Archive
The Visiting Nurse Association of Greater Philadelphia has received a grant award from the First Hospital Foundation in the amount of $40,000. The grant will be used to enhance the VNA's Wound Care Program and will enable the agency to purchase digital cameras so the home visiting clinicians can document patients wound progression and improve wound care delivery.
BioMarin Pharmaceutical Inc. announced today that it has received orphan drug designation from the U.S. Food and Drug Administration (FDA) for BMN-701, a novel fusion of insulin-like growth factor 2 and alpha glucosidase (IGF2-GAA) in development for the treatment of Pompe disease. An investigational new drug application (IND) for BMN-701 has been submitted, investigational material has been manufactured and a Phase I/II study is expected to start in the first quarter of 2011.
K2M, Inc., today announced at the International Society for the Advancement of Spine Surgery (SAS) Conference that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the EVEREST™ Degenerative Spinal System, a versatile top-loading polyaxial pedicle screw system featuring the ability to accommodate multiple levels of fixation rigidity to help surgeons individualize patient care.
A team of researchers in Poland who treated three of six paraplegics with spinal cord injury using transplanted olfactory ensheathing cells found that the three treated patients showed neurological improvement and no adverse effects while the three control patients who did not receive transplants saw no improvement.
› Verified 3 days ago
Dr. Richard Pitera, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 4855 W Hillsboro Blvd, Suite B7, Coconut Creek, FL 33073 Phone: 954-974-5820 Fax: 954-975-7517 |